Filing Details
- Accession Number:
- 0001209191-21-055500
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-10 17:21:20
- Reporting Period:
- 2021-05-28
- Accepted Time:
- 2021-09-10 17:21:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 2525 West End Ave. Suite 950 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-28 | 15 | $2.93 | 5,768,184 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-01 | 15 | $2.94 | 5,768,199 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-02 | 15 | $2.89 | 5,768,214 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-03 | 15 | $2.81 | 5,768,229 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-04 | 15 | $2.93 | 5,768,244 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-07 | 15 | $2.94 | 5,768,259 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-08 | 15 | $2.99 | 5,768,274 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-09 | 15 | $3.14 | 5,768,289 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-10 | 15 | $3.25 | 5,768,304 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-11 | 15 | $3.18 | 5,768,319 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-14 | 15 | $3.09 | 5,768,334 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-15 | 15 | $3.09 | 5,768,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-16 | 15 | $3.09 | 5,768,364 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-17 | 15 | $3.08 | 5,768,379 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-18 | 15 | $2.99 | 5,768,394 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-21 | 15 | $3.14 | 5,768,409 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-22 | 15 | $3.05 | 5,768,424 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-23 | 15 | $3.07 | 5,768,439 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-24 | 15 | $3.09 | 5,768,454 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-25 | 15 | $3.09 | 5,768,469 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-28 | 15 | $3.16 | 5,768,484 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-29 | 15 | $3.03 | 5,768,499 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-30 | 15 | $2.93 | 5,768,514 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Billionaire Hedge Funds
